QIAGEN, Personalized Medicine Coalition, and C3: Colorectal Cancer Coalition to Discuss How Advances in Personalized Medicine Can Better Help Patients and Cut the Cost of Care NEW YORK — The treatment of illness has traditionally been based on the law of averages – what works best for the largest number of patients. As a result, […]
Runcorn, Cheshire, United Kingdom — Thermo Fisher Scientific (NYSE: TMO) to supply OPTEC, LLC with Cancer Diagnostic Instrumentation as Part of National Oncological Program in Russia. Thermo Fisher Scientific, the world leader in serving science, today announced a distribution partnership with OPTEC LLC, the leading provider of cutting-edge medical, surgical, microscopic and industrial metrology solutions […]
Salt Lake City, UT — Idaho Technology, Inc. (ITI) announced today that clinical trials of the FilmArray Respiratory Panel (RP) have commenced at three US Hospital Laboratories. “We believe that the FilmArray RP holds tremendous potential for hospital clinical laboratories frustrated with the hassle, long turnaround times, and inferior sensitivity and specificity of viral culture, […]
Pioneer in antibody selection unveils powerful technology to use high performance antibodies on genomics platforms BRANFORD, Conn.–Affomix Corporation, a pioneer in high performance antibody technology, announced today a collaboration with City of Hope focused on establishing the clinical utility of “digital proteomics” with next generation sequencers. One of the nation’s top cancer research and treatment […]
SAN DIEGO — Sequenom, Inc. (Nasdaq: SQNM), announced today the entry of a settlement agreement which will resolve the consolidated securities class action lawsuits, In re Sequenom, Inc. Securities Litigation, Master File No: 3:09-cv-00921-LAB-WMC. The defendants have agreed to pay $14 million, which will be funded by insurance proceeds. Additionally the company has agreed to […]
Company to leverage new production site to capture growth in China and expand Point of Care and rapid diagnostics offer for both emerging and developed countries MARCY L’ETOILE, France, Jan. 14 — A world leader in in vitro diagnostics, bioMerieux announced today the acquisition of the rapid test manufacturer, Meikang Biotech, and its large production […]
NEW YORK–Enzo Biochem, Inc. (NYSE: ENZ) announced today that its Enzo Clinical Labs division has become one of the first diagnostic laboratories to make available a rapid and sensitive H1N1 PCR test for the swine flu virus. Enzo Clinical Labs serves physicians throughout the Metropolitan New York area, as well as New Jersey and parts […]
Applications of Newly Added Molecular Detection Technology Include Point-of-Need Testing in Molecular Diagnostics and Applied Testing VENLO, The Netherlands — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that it has acquired ESE GmbH, a privately held developer and manufacturer of UV and fluorescence optical measurement devices. ESE is based in Stockach, Germany. […]
Acquisition Adds to Company’s Strengths in Molecular Diagnostic Offerings CARLSBAD, Calif.–Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire AcroMetrix, for an undisclosed amount. “Our customers will now benefit from even greater investment in new molecular products designed to meet the […]
WASHINGTON — Danaher Corporation (NYSE: DHR) announced today that it has acquired and received acceptances in respect of approximately 97% of the currently issued shares of Genetix Group plc (GTX: AIM) in relation to its previously announced offer dated December 18, 2009. Danaher intends to acquire any common shares of Genetix that remain untendered through […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
